Skip to main content

Medical Professional Video Center

Home
Specialties

Search Video Center

Refer Your Patient

Drug can diminish the symptoms and burden of myelofibrosis

Ruben A. Mesa, M.D., discusses how the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis.

Access Restricted

You must provide the password to continue.

Password:

HELPFUL LINKS

Request An Appointment
Make A Donation
Contact Us
About Mayo Clinic
Employees
Site Map

Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.

Terms and Conditions
Privacy Policy
Notice of Privacy Practices

Mayo Clinic is a not-for-profit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.

Advertising and sponsorship policy
Advertising and sponsorship opportunities

A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Powered by BROADCASTMED
BroadcastMed Privacy Policy

© 1998- Mayo Foundation for Medical Education and Research. All rights reserved.